Open Access

Transforming growth factor‑β family and stem cell‑derived exosome therapeutic treatment in osteoarthritis (Review)

  • Authors:
    • Kwang Ho Yoo
    • Nikita Thapa
    • Yong Joon Chwae
    • Seung Hyun Yoon
    • Beom Joon Kim
    • Jung Ok Lee
    • You Na Jang
    • Jaeyoung Kim
  • View Affiliations

  • Published online on: March 10, 2022     https://doi.org/10.3892/ijmm.2022.5118
  • Article Number: 62
  • Copyright : © Yoo et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Osteoarthritis (OA), although extensively researched, still lacks an effective and safe treatment. The only current treatment option available for advanced OA is joint replacement surgery. This surgery may pose the risks of persistent pain, surgical complications and limited implant lifespan. Transforming growth factor (TGF)‑β has a crucial role in multiple cellular processes such as cell proliferation. Any deterioration in TGF‑β signaling pathways can have an immense impact on OA. Owing to the crucial role of TGF‑β in cartilage homeostasis, targeting it could be an alternative therapeutic approach. Additionally, stem cell‑based therapy has recently emerged as an effective treatment strategy that could replace surgery. A number of recent findings suggest that the tissue regeneration effect of stem cells is attributed to the paracrine secretion of anti‑inflammatory and chondroprotective mediators or trophic factors, particularly nanosized extracellular vesicles (i.e., exosomes). Literature searches were performed in the MEDLINE, EMBASE, Cochrane Library and PubMed electronic database for relevant articles published before September 2021. Multiple investigators have confirmed TGF‑β3 as a promising candidate which has the chondrogenic potential to repair articular cartilage degeneration. Combining TGF‑β3 with bone morphogenetic proteins‑6, which has synergistic effect on chondrogenesis, with an efficient platform such as exosomes, which themselves possess a chondroprotective function, offers an innovative and more efficient approach to treat injured cartilage. In addition, multiple findings stating the role of exosomes in chondroprotection has also verified a similar fact showing exosomes may be a more favorable choice than the source itself. In the present review, the importance of TGF‑β family in OA and the possibility of therapeutic treatment using stem cell‑derived exosomes are described.
View Figures
View References

Related Articles

Journal Cover

May-2022
Volume 49 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yoo KH, Thapa N, Chwae YJ, Yoon SH, Kim BJ, Lee JO, Jang YN and Kim J: Transforming growth factor‑β family and stem cell‑derived exosome therapeutic treatment in osteoarthritis (Review). Int J Mol Med 49: 62, 2022.
APA
Yoo, K.H., Thapa, N., Chwae, Y.J., Yoon, S.H., Kim, B.J., Lee, J.O. ... Kim, J. (2022). Transforming growth factor‑β family and stem cell‑derived exosome therapeutic treatment in osteoarthritis (Review). International Journal of Molecular Medicine, 49, 62. https://doi.org/10.3892/ijmm.2022.5118
MLA
Yoo, K. H., Thapa, N., Chwae, Y. J., Yoon, S. H., Kim, B. J., Lee, J. O., Jang, Y. N., Kim, J."Transforming growth factor‑β family and stem cell‑derived exosome therapeutic treatment in osteoarthritis (Review)". International Journal of Molecular Medicine 49.5 (2022): 62.
Chicago
Yoo, K. H., Thapa, N., Chwae, Y. J., Yoon, S. H., Kim, B. J., Lee, J. O., Jang, Y. N., Kim, J."Transforming growth factor‑β family and stem cell‑derived exosome therapeutic treatment in osteoarthritis (Review)". International Journal of Molecular Medicine 49, no. 5 (2022): 62. https://doi.org/10.3892/ijmm.2022.5118